Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator
Key facts
- Who runs it
- The Cleveland Clinic
- Where
- Cleveland, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 2 people enrolled
- Started
- 1 Oct 2025
- Ended
- 1 Feb 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Vasopressin
- Record updated
- 19 February 2026
- Why it stopped
- The study was terminated due to lack of feasibility.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Adult patients (≥18 years old)
- Septic shock (as defined by Sepsis-3)
- Receiving norepinephrine
- Admitted to a medical, surgical, NeuroSciences, or mixed intensive care unit
- Central venous catheter in place
- Ordered fixed-dose vasopressin as an adjunct to norepinephrine by the primary care team (unless in active control cohort)
Who cannot take part
- Receiving a primary vasopressor other than norepinephrine (eg, phenylephrine)
- Positive test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the preceding 28 days
- Blood hemoglobin concentration <7 g/dL
- Vasopressin ordered for an indication other than septic shock
- Vasopressin initiated at another institution
- Primary treatment team determines that vasopressin initiation is emergent
- Patient or their legal authorized representative opts to not participate in the study
Where in United States
- Cleveland Clinic - Main CampusCleveland, United States
About the trial
What the trial wants to find out
The goal of this observational study is to learn about blood pressure response to the vasopressor drug vasopressin in people with septic shock.
Read full original descriptionShow less
The main questions it aims to answer are:
* Are the levels of molecules showing communication between cells different between people whose blood pressure improves and people whose blood pressure does not improve when given a vasopressor medication? * Are measurements found on echocardiography (heart ultrasound) different between people whose blood pressure improves and people whose blood pressure does not improve when given a vasopressor medication? * Are measurements of blood oxygen in tissues just below the skin different between people whose blood pressure improves and people whose blood pressure does not improve when given a vasopressor medication?
Participants will be asked to contribute one or two blood samples. Participants who are ordered the drug vasopressin will contribute two blood samples. Both samples will be about two tablespoons for a total of about four tablespoons. One sample will be drawn before starting vasopressin infusion and the second sample will be drawn between one and six hours after starting the vasopressor drug infusion. At the same time points, advanced echocardiography pictures and measurements of oxygen in tissues from a sensor placed on one of the hands will be taken. Participants who are not ordered the drug vasopressin and only ordered the drug norepinephrine will contribute only one blood sample. At the time the sample is collected, advanced echocardiography pictures and measurements of oxygen in tissues from a sensor placed on one of the hands will be taken. This research also involves analyzing data obtained during the participant's hospital stay.
The 2 groups in the trial
- Vasopressin plus norepinephrine
Patients with septic shock ordered vasopressin as an adjunct to norepinephrine
Treatment: Vasopressin
- Norepinephrine
Active control cohort of patients with septic shock who are only receiving norepinephrine
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 19 February 2026